Part II: Cancer in Indigenous Africans--causes and control.
about
Understanding, beliefs and perspectives of Aboriginal people in Western Australia about cancer and its impact on access to cancer services.Breast cancer in Sub-Saharan Africa: opportunities for prevention.Prostate Cancer Detected by Screening in a Semi Urban Community in Southeast Nigeria: Correlations and Associations between Anthropometric Measurements and Prostate-specific Antigen.HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries.Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities.Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey.On the antiquity of cancer: evidence for metastatic carcinoma in a young man from ancient Nubia (c. 1200 BC).Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent?Trends in cancer incidence in Maputo, Mozambique, 1991-2008.Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up.The prioritisation of paediatrics and palliative care in cancer control plans in AfricaCancer in Angola, resources and strategy for its control.Chromosomal radiosensitivity of human immunodeficiency virus positive/negative cervical cancer patients in South Africa.An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaInternational pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics.Evaluating health and disease in Sub-Saharan Africa: minimally invasive collection of plasma in the Malawi Longitudinal Study of Families and Health (MLSFH)Cancer burden in Africa and opportunities for prevention.Developing World ENT: a global responsibility.Kaposi's sarcoma-associated herpesvirus ORF57 protein: exploiting all stages of viral mRNA processing.Cancer prevention in Africa: a review of the literature.Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda.Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort studyPreventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa).Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania.Health research in Africa: getting priorities right.Descriptive Epidemiology of Cancers in Togo from 2009 to 2016HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women.The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study.Weak surveillance and policy attention to cancer in global health: the example of Mozambique.
P2860
Q33488726-FEA07889-6F09-4125-919B-2C2A72218801Q33622597-8DF340DD-0DE1-469F-A32F-BABB09E6F02AQ33717961-9F275EC9-F912-4A7A-B00B-692303FD7319Q34049757-93FBB038-439B-4723-99A2-E242EF8FE582Q34150020-F2B96B35-FEA3-4FE0-BE61-42CA18F1AA39Q34193400-44446478-F5A0-4E84-AB33-B06B67A7D07DQ34365480-C4C5EFB1-0ABA-4CD9-83CD-9F12229F5D3FQ34479111-D7528E6A-FDA9-4B3B-ACAF-9F78FEF72AA5Q35123121-B9CF859C-4940-4037-9756-0B2C8B6FF173Q35360144-ED32D387-4D33-426A-A406-EB96F4B0CEF5Q35630020-C3C5AF4A-B0A0-420B-B249-4FA7801B0EA5Q35674276-EFB1E5EC-8E95-4266-B9E4-C6603D04AEC2Q36064814-BC942E16-DA82-4E28-AB3B-D305DDF1B648Q36086840-C8810B24-F2DF-45AB-B8FB-F8D3DED317FFQ36095355-AF7A0864-5700-4D6B-9BB2-1936F5F182BBQ36390334-4490EAF2-0974-4BEF-BA0F-87A20EC463D7Q36405019-379BFD48-0A23-4E3C-A8DD-D2218A3FD903Q37067875-7535CFA3-62C5-43AE-925F-1008FAC1AAB9Q37190568-12839E75-8CB0-46AF-998F-730844D9096CQ37976577-76F0A1A5-63B0-4078-9820-F3F88B5B6138Q37998230-D4B9ECB3-E3C9-4CD2-97B6-D04EBD4128CFQ38125077-D9F02151-7AED-4E9B-B300-2A49BDBBCE74Q38229949-7823F633-E12B-4AA7-8CCD-693D22364CE6Q38779952-73B011AD-4089-40A6-9F53-B6A72D99D459Q38870017-D680A16D-2AA7-4882-95AB-0D5A8FF46525Q39373193-DBF1000B-4FEE-4F0F-B097-6ED246C3BE37Q41686395-2EE6C695-E32D-4383-A99C-07D858CE51EEQ42035960-0ED9D62E-9450-4E2D-8412-42B70D4AF66BQ43506189-01BEE973-EB91-499D-826C-33E3FFBE9D93Q44563619-FF752F65-66DB-47CF-B2D4-6E074D7F41B5Q47234507-54B9AD70-3E01-4912-A14C-FFCD3D811B26Q49232494-F86EF07A-D23E-4BDF-AF3F-99320258D13AQ50241779-EF509567-30DF-4CF2-B057-7B322E38CA32Q50503896-22D72275-A91A-4988-806D-551DA2B2009DQ55456363-C847E574-A054-45E9-B427-1B590608E128
P2860
Part II: Cancer in Indigenous Africans--causes and control.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Part II: Cancer in Indigenous Africans--causes and control.
@en
Part II: Cancer in Indigenous Africans--causes and control.
@nl
type
label
Part II: Cancer in Indigenous Africans--causes and control.
@en
Part II: Cancer in Indigenous Africans--causes and control.
@nl
prefLabel
Part II: Cancer in Indigenous Africans--causes and control.
@en
Part II: Cancer in Indigenous Africans--causes and control.
@nl
P2093
P1433
P1476
Part II: Cancer in Indigenous Africans--causes and control
@en
P2093
D Max Parkin
Henry Wabinga
Lara Stein
Mike Chirenje
Raymond Abratt
P304
P356
10.1016/S1470-2045(08)70198-0
P50
P577
2008-08-01T00:00:00Z